source
- A year after Vertex’s big launch, pain drug research faces a pivotal momentJournavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?BioPharma Dive · 2mo ago↗ source
- Flagship startup Serif says it has solved non-viral gene therapy in monkeysBOSTON — Serif Biomedicines, a startup launched last month by Flagship Pioneering, believes it has solved two technical challenges that have long prevented gene therapy from being delivered without…Endpoints · 2mo ago↗ source
- Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2BIt's becoming Hengrui Pharma's world, and some Western drugmakers are just living in it. China's largest pharma company, which boasts one of the biggest pipelines in the industry, has lined up Bris…